Analysis of tissue inhibitor of metalloproteinase-2 gene polymorphisms in a caucasian population with abdominal aortic aneurysms;Analyse von genvarianten des gewebeinhibitors der metalloproteinase-2 (TIMP-2) bei patienten mit abdominalem aortenaneurysma

Zentralblatt fur Chirurgie - Zeitschrift fur Allgemeine, Viszeral- und Gefasschirurgie

Volumn 133, Issue 4, 2008, Pages 332-337

  Hinterseher, Irene ^a   Krex, D ^a   Kuhlisch, E ^b   Pilarsky, C ^a   Schneiders, W ^a   Saeger, H D ^a   Bergert, H ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Abdominal aortic aneurysm; Genetics; Polymorphism; TIMP 2

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ABDOMINAL AORTA ANEURYSM; AGED; ALLELE; ARTICLE; FEMALE; GENE FREQUENCY; GENETIC SCREENING; GENETICS; GENOTYPE; HUMAN; INTRON; MALE; MIDDLE AGED; PHENOTYPE; POPULATION GENETICS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALLELES; AORTIC ANEURYSM, ABDOMINAL; FEMALE; GENE FREQUENCY; GENETIC SCREENING; GENETICS, POPULATION; GENOTYPE; HUMANS; INTRONS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 50249167288     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1076862     Document Type: Article

References (34)

1. Annabi B, Shédid D, Ghosh P et al. Differential regulation of matrix metalloproteinase activies in abdominal aortic aneurysms. J Vasc Surg 2002; 35: 539-546
2. Bickerstaff LK, Hollier LH, Van Peenen HJ et al. Abdominal aortic aneurysms: the changing natural history. J Vasc Surg 1984; 1: 6-12
3. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000; 1477: 267-283
4. Brophy CM, Marks WH, Reilly JM et al. Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: a preliminary report. JSR 1991; 50: 653-657
5. Busuttil RW, Abou-Zamzam A, Machleder HI. Collagenase activity of the human aorta. Arch Surg 1980; 115: 1373-1378
6. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361: 865-872
7. Crowther M, Bundle JV, Sayers R et al. Aneurysmal smooth muscle cells exhibit increased matrix metalloproteinase-2 production in vitro. Ann N Y Acad Sci 1996; 800: 283-285
8. Darling IIIRC, Brewster DC, Darling RC et al. Are familial abdominal aortic aneurysms different? J Vasc Surg 1989; 10: 39-43
9. Davis VA, Persidskaia R, Baca-Regen L et al. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Thromb Vasc Biol 1998; 18: 1625-1633
10. Defawe OD, Colige A, Lambert CA et al. TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas. Cardiovasc Surg 2003; 60: 205-213
11. den Dunnen J, Antonarakis E. Nomenclature for the description of human sequence variations. Hum Genet 2001; 109: 121-124
12. Dobrin PB, Mrkvicka R. Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc Surg 1994; 2: 484-488
13. Ernst C. Abdominal aortic aneurysm. N Engl J Med 1993; 328: 1167-1172
14. Freestone T, Turner RJ, Coady A et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995; 15: 1145-1151
15. Hinterseher I, Bergert H, Kuhlisch E et al. Matrix metalloproteinase 2 polymorphisms in a Caucasian population with abdominal aortic aneurysm. JSR 2006; 133: 121-128
16. Johansen K, Koepsell T. Familial tendency for abdominal aortic aneurysm. JAMA 1986; 256: 1934-1936
17. Jones K, Brull D, Brown L et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001; 103: 2260-2265
18. Keeling W, Armstrong P, Stone P et al. An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovasc Surg 2005; 39: 457-464
19. Krex D, Röhl H, König I et al. Tissue Inhibitor of Metalloproteinases-1, -2, and -3 polymorphisms in a white population with intracranial aneurysms. Stroke 2003; 34: 2817-2821
20. McKusick VA. The defect in Marfan syndrome. Nature 1991; 352: 279-281
21. McMillan WD, Patterson BK, Keen RR et al. In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta. J Vasc Surg 1995; 22: 295-305
22. Mitchell M, Rutherford R, Krupski W. Infrarenal aortic aneurysms. In: Rutherford R, Hrsg. Vascular Surgery. Philadelphia: WB Saunders; 1995:1032-1060
23. Nakamura M, Tachieda R, Niinuma H et al. Circulating biochemical marker levels of collagen metabolism are abnormal in patients with abdominal aortic aneurysm. Angiology 2000; 51: 385-392
24. Ogata T, Shibamura H, Tromp G et al. Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. J Vasc Surg 2005; 41: 1036-1042
25. Patel MI, Melrose J, Ghosh P et al. Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg 1996; 24: 82-92
26. Rebbeck TR, Martinez ME, Sellers TA et al. Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev 2004; 13: 1985-1986
27. Sakalihasan N, Delvenne P, Nusgens BV et al. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 1996; 24: 127-133
28. Superti-Furga A, Steinmann B, Ramirez F et al. Molecular defects of type III procollagen in Ehlers-Danlos syndrome type IV. Hum Genet 1989; 82: 104-108
29. Tamarina N, McMillan WD, Shively VP et al. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 1997; 122: 264-272
30. Tilson MD, Reilly JM, Brophy CM et al. Expression and sequence of the gene for tissue inhibitor of metalloproteases in patients with abdominal aortic aneurysms. J Vasc Surg 1993; 18: 266-270
31. Tromp G, Wu Y, Prockop DJ et al. Sequencing of cDNA from 50 unrelated patients reveals that mutations in the triple-helical domain of type III procollagen are an infrequent cause of aortic aneurysms. J Clin Invest 1993; 91: 2539-2545
32. Wang X, Tromp G, Cole CW et al. Analysis of coding sequences for tissue inhibitor of metalloproteinases 1 (TIMP1) and 2 (TIMP2) in patients with aneurysms. Matrix Biol 1999; 18: 121-124
33. Webster EL, Ferrell RE, St. Jean PL et al. Ultrasound screening of first-degree relatives of patients with an abdominal aortic aneurysm. J Vasc Surg 1991; 13: 9-14
34. Yoon S, Tromp G, Vongpunsawad S et al. Genetic analysis of MMP3, MMP9 and PAI-1 in finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 1999; 265: 563-568